Accessing HIV Testing and Harm Reduction through Smart Vending Machines
Reaching HIV Undiagnosed: Implementation and Evaluation of Interactive Dispensing Systems for Low-barrier Access to Rapid Testing and Harm Reduction Supplies With Linkage to Care for Marginalized and Hard-to-reach Populations in Canada.
This study is testing whether smart vending machines can help people in Canada access HIV self-testing and harm reduction supplies more easily, especially those who face challenges getting healthcare.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 5000 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | Unity Health Toronto Academic / other |
| Locations | 1 site (Moncton, New Brunswick) |
| Trial ID | NCT05516069 on ClinicalTrials.gov |
What this trial studies
This program aims to improve access to HIV self-testing and harm reduction materials by deploying 'smart' interactive vending machines across Canada. The initiative targets individuals facing systemic and structural barriers to healthcare, such as those with chaotic life circumstances or addiction challenges. By collaborating with local community organizations, the program seeks to connect these individuals to essential health resources and support. The goal is to roll out 100 vending machines over three years, enhancing equitable access to healthcare for all Canadians.
Who should consider this trial
Good fit: Ideal candidates include Canadian residents aged 16 and older who face barriers to accessing traditional healthcare services.
Not a fit: Patients who do not meet the inclusion criteria or those who have reliable access to healthcare services may not benefit from this program.
Why it matters
Potential benefit: If successful, this initiative could significantly increase access to HIV testing and harm reduction resources for marginalized populations.
How similar studies have performed: Other studies have shown success in improving access to healthcare through innovative distribution methods, suggesting potential for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 16 years or older (except for Quebec: age 18 years or older) * Person living in Canada (Canadian resident) * Able to provide consent in English or French (via the machine screen) Exclusion Criteria: * Does not meet all inclusion criteria
Where this trial is running
Moncton, New Brunswick
- Ensemble — Moncton, New Brunswick, Canada (Recruiting)
Study contacts
- Principal investigator: Sean B Rourke, PhD — MAP Centre for Urban Health Solutions, St. Micheal's Hospital
- Study coordinator: Sean B Rourke, PhD
- Email: sean.rourke@utoronto.ca
- Phone: (416) 878-2779
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.